The Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Monday follows:

Annaly Capital Management Inc. (NYSE:NLY) was started with a Buy rating at UBS with a 9.50 target. That compares to the consensus target on Wall Street of 10.10.

Fiserv Inc. (NASDAQ:FISV) was started with a Buy rating at Raymond James with a 103 price objective. That compares with the Wall Street consensus which is set at 98.65.

KeyCorp (NYSE:KEY) is raised to Outperform from Neutral at Baird.

Mustang Bio Inc. (NASDAQ:MBIO) was started with a Buy rating at Cantor Fitz with a 7 target. That compares with a consensus target at 19.50.

Phillips 66 (NYSE:PSX) is raised to Buy from Neutral at Citigroup. The consensus price target for the company is posted at 116.87.

Sarepta Therapeutics Inc (NASDAQ:SRPT) is being called among the Top picks at Merrill Lynch for the rest of Y 2019. The biotech has traded between 95.21 and 165.87 over the last year. Shares last seen at 129.79 Friday.

Have a terrific week

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :